Health Condition 1: F524- Premature ejaculation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Subjects diagnosed with Premature Ejaculation as per ISSM (International Society of Sexual Medicine) and ICD-10 (2) Subjects consenting to be sexually active (intravaginal intercourse) during the study period (3) Subjects providing written informed consent
Exclusion criteria
Exclusion criteria: 1. Subjects who have used investigational drug (Dapoxetine) within the past 1 month 2. Subjects not having consistent sexual partner in heterosexual relationship 3. Subjects having a medical condition(s) which could affect sexual functioning 4. Subjects on psychotropics medication or other drug which are known to either affect sexual functioning or cause drug interaction with the investigational drug (Dapoxetine) 5. Subjects not having any co-morbid psychiatric condition which may affect sexual functioning 6. Subjects using the substance known to affect sexual functioning
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IELT (Intravaginal Ejaculatory Latency Time)Timepoint: one time during the preparation phase (within the first 2 weeks of the start of the study) and then 3 times at 4 weekly intervals during the intervention phase ( at 6 week, 10 week, 14 weeks) | — |
Secondary
| Measure | Time frame |
|---|---|
| Premature ejaculation diagnostic tool (PEDT) ScoreTimepoint: one time during the preparation phase (within the first 2 weeks of the start of the study) and then 3 times at 4 weekly intervals during the intervention phase ( at 6 week, 10 week, 14 weeks) | — |
Countries
India
Contacts
All India Institute of Medical Sciences